Targeted epigenetic therapies: the next frontier?
Rabiya S
RS
Tuma
D018262:Adenocarcinoma, Clear Cell / Q000235:genetics* / Q000628:therapy*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics; D000090205:DNA Methyltransferase 3A; D004268:DNA-Binding Proteins / Q000235:genetics; D000071221:Enhancer of Zeste Homolog 2 Protein; D044127:Epigenesis, Genetic / Q000187:drug effects*; D005260:Female; D017353:Gene Deletion; D056466:Histone Demethylases; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends; D009154:Mutation / Q000187:drug effects; D009687:Nuclear Proteins / Q000235:genetics; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000628:therapy*; D063151:Polycomb Repressive Complex 2; D000071796:SMARCB1 Protein; D014157:Transcription Factors / Q000235:genetics
C112476:ARID1A protein, human; D000970:Antineoplastic Agents; D002868:Chromosomal Proteins, Non-Histone; D004268:DNA-Binding Proteins; C000717967:DNMT3A protein, human; D009687:Nuclear Proteins; D000071796:SMARCB1 Protein; C513266:SMARCB1 protein, human; D014157:Transcription Factors; D056466:Histone Demethylases; C523998:KDM6A protein, human; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; C498409:EZH2 protein, human; D000071221:Enhancer of Zeste Homolog 2 Protein; D063151:Polycomb Repressive Complex 2